Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China
· Delayed Price · Currency is CNY 9.71
-0.13 (-1.32%)
Apr 30, 2025, 3:00 PM CST
SHA:603998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 4,264 | 4,819 | 3,521 | 2,920 | 2,572 | 3,606 | Upgrade
|
| Market Cap Growth | 8.69% | 36.87% | 20.58% | 13.52% | -28.67% | 80.17% | Upgrade
|
| Enterprise Value | 4,752 | 5,463 | 3,898 | 3,469 | 2,836 | 3,867 | Upgrade
|
| Last Close Price | 9.71 | 10.65 | 7.57 | 6.17 | 5.38 | 7.32 | Upgrade
|
| PE Ratio | 16.05 | 25.80 | 12.32 | 41.69 | 40.32 | 45.70 | Upgrade
|
| Forward PE | 13.24 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | Upgrade
|
| PS Ratio | 2.42 | 2.96 | 1.97 | 1.86 | 2.01 | 3.30 | Upgrade
|
| PB Ratio | 2.49 | 3.03 | 2.34 | 2.24 | 2.03 | 3.00 | Upgrade
|
| P/TBV Ratio | 4.00 | 5.26 | 4.05 | 5.15 | 3.82 | 5.70 | Upgrade
|
| P/FCF Ratio | 40.96 | - | 27.01 | 3188.95 | 37.33 | - | Upgrade
|
| P/OCF Ratio | 19.74 | 55.06 | 11.67 | 15.73 | 10.87 | 22.18 | Upgrade
|
| EV/Sales Ratio | 2.70 | 3.35 | 2.17 | 2.21 | 2.22 | 3.54 | Upgrade
|
| EV/EBITDA Ratio | 16.47 | 23.31 | 17.43 | 18.18 | 17.46 | 28.12 | Upgrade
|
| EV/EBIT Ratio | 22.21 | 33.45 | 25.31 | 28.12 | 30.84 | 46.17 | Upgrade
|
| EV/FCF Ratio | 45.66 | - | 29.90 | 3788.09 | 41.16 | - | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.43 | 0.39 | 0.42 | 0.35 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 2.45 | 2.88 | 2.56 | 2.74 | 2.73 | 2.25 | Upgrade
|
| Debt / FCF Ratio | 6.80 | - | 4.56 | 602.87 | 6.43 | - | Upgrade
|
| Asset Turnover | 0.55 | 0.54 | 0.64 | 0.63 | 0.60 | 0.60 | Upgrade
|
| Inventory Turnover | 1.36 | 1.65 | 2.10 | 2.43 | 2.25 | 1.51 | Upgrade
|
| Quick Ratio | 0.41 | 0.38 | 0.80 | 0.45 | 0.62 | 0.56 | Upgrade
|
| Current Ratio | 0.75 | 0.74 | 1.19 | 0.69 | 0.91 | 0.94 | Upgrade
|
| Return on Equity (ROE) | 16.27% | 11.60% | 19.68% | 5.44% | 4.36% | 6.82% | Upgrade
|
| Return on Assets (ROA) | 4.18% | 3.40% | 3.42% | 3.12% | 2.71% | 2.88% | Upgrade
|
| Return on Capital (ROIC) | 5.69% | 4.67% | 4.86% | 4.33% | 3.57% | 3.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.30% | 8.90% | 8.00% | 8.50% | 6.70% | 6.40% | Upgrade
|
| Earnings Yield | 6.40% | 3.88% | 8.12% | 2.40% | 2.48% | 2.19% | Upgrade
|
| FCF Yield | 2.44% | -2.72% | 3.70% | 0.03% | 2.68% | -1.02% | Upgrade
|
| Dividend Yield | 2.57% | 2.72% | 4.63% | 2.43% | 2.23% | 0.82% | Upgrade
|
| Payout Ratio | 45.90% | 93.36% | 43.27% | 66.85% | 107.45% | 32.64% | Upgrade
|
| Buyback Yield / Dilution | -4.55% | -2.70% | 1.06% | -2.93% | 2.99% | -2.10% | Upgrade
|
| Total Shareholder Return | -1.98% | 0.02% | 5.69% | -0.50% | 5.22% | -1.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.